vs

Side-by-side financial comparison of Immunocore Holdings plc (IMCR) and Resolute Holdings Management, Inc. (RHLD). Click either name above to swap in a different company.

Resolute Holdings Management, Inc. is the larger business by last-quarter revenue ($117.7M vs $104.5M, roughly 1.1× Immunocore Holdings plc). Resolute Holdings Management, Inc. produced more free cash flow last quarter ($189.2M vs $-35.5M).

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

Resolute Mining Limited is an Australian mining corporation focused on mining operations in Africa. It is currently operating two gold mines: the Syama Gold Mine in Mali and the Mako Gold Mine in Senegal.

IMCR vs RHLD — Head-to-Head

Bigger by revenue
RHLD
RHLD
1.1× larger
RHLD
$117.7M
$104.5M
IMCR
More free cash flow
RHLD
RHLD
$224.8M more FCF
RHLD
$189.2M
$-35.5M
IMCR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IMCR
IMCR
RHLD
RHLD
Revenue
$104.5M
$117.7M
Net Profit
$-1.7M
Gross Margin
97.4%
55.7%
Operating Margin
-18.8%
30.2%
Net Margin
-1.5%
Revenue YoY
24.3%
Net Profit YoY
EPS (diluted)
$-0.61
$-0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMCR
IMCR
RHLD
RHLD
Q4 25
$104.5M
$117.7M
Q3 25
$103.7M
$120.9M
Q2 25
$98.0M
$119.6M
Q1 25
$93.9M
$103.9M
Q4 24
$84.1M
Q3 24
$80.2M
Q2 24
$75.4M
Q1 24
$70.5M
Net Profit
IMCR
IMCR
RHLD
RHLD
Q4 25
$-1.7M
Q3 25
$-177.0K
$-231.0K
Q2 25
$-10.3M
$-611.0K
Q1 25
$5.0M
$-3.4M
Q4 24
Q3 24
$8.7M
Q2 24
$-11.6M
Q1 24
$-24.4M
Gross Margin
IMCR
IMCR
RHLD
RHLD
Q4 25
97.4%
55.7%
Q3 25
99.5%
59.0%
Q2 25
98.9%
57.5%
Q1 25
99.1%
52.5%
Q4 24
99.6%
Q3 24
99.4%
Q2 24
97.7%
Q1 24
99.7%
Operating Margin
IMCR
IMCR
RHLD
RHLD
Q4 25
-18.8%
30.2%
Q3 25
-6.9%
34.3%
Q2 25
-15.2%
34.0%
Q1 25
-3.9%
24.7%
Q4 24
-23.1%
Q3 24
-10.6%
Q2 24
-21.2%
Q1 24
-37.6%
Net Margin
IMCR
IMCR
RHLD
RHLD
Q4 25
-1.5%
Q3 25
-0.2%
-0.2%
Q2 25
-10.5%
-0.5%
Q1 25
5.4%
-3.2%
Q4 24
Q3 24
10.9%
Q2 24
-15.4%
Q1 24
-34.7%
EPS (diluted)
IMCR
IMCR
RHLD
RHLD
Q4 25
$-0.61
$-0.20
Q3 25
$0.00
$-0.03
Q2 25
$-0.20
$-0.07
Q1 25
$0.10
$-0.39
Q4 24
$-0.47
Q3 24
$0.17
Q2 24
$-0.23
Q1 24
$-0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMCR
IMCR
RHLD
RHLD
Cash + ST InvestmentsLiquidity on hand
$864.2M
$205.5M
Total DebtLower is stronger
$169.8M
Stockholders' EquityBook value
$381.0M
$6.5M
Total Assets
$1.1B
$333.4M
Debt / EquityLower = less leverage
26.03×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMCR
IMCR
RHLD
RHLD
Q4 25
$864.2M
$205.5M
Q3 25
$892.4M
$148.0M
Q2 25
$882.8M
$99.9M
Q1 25
$837.0M
$71.0M
Q4 24
$820.4M
Q3 24
$901.3M
Q2 24
$859.6M
Q1 24
$832.8M
Total Debt
IMCR
IMCR
RHLD
RHLD
Q4 25
$169.8M
Q3 25
$173.4M
Q2 25
$177.1M
Q1 25
$180.7M
Q4 24
Q3 24
$438.7M
Q2 24
$452.5M
Q1 24
$452.5M
Stockholders' Equity
IMCR
IMCR
RHLD
RHLD
Q4 25
$381.0M
$6.5M
Q3 25
$396.6M
$10.8M
Q2 25
$388.5M
$9.6M
Q1 25
$378.5M
$8.9M
Q4 24
$360.7M
Q3 24
$377.8M
Q2 24
$359.1M
Q1 24
$359.5M
Total Assets
IMCR
IMCR
RHLD
RHLD
Q4 25
$1.1B
$333.4M
Q3 25
$1.1B
$293.2M
Q2 25
$1.1B
$253.3M
Q1 25
$1.0B
$214.3M
Q4 24
$1.0B
Q3 24
$1.1B
Q2 24
$1.0B
Q1 24
$994.0M
Debt / Equity
IMCR
IMCR
RHLD
RHLD
Q4 25
26.03×
Q3 25
16.01×
Q2 25
18.42×
Q1 25
20.38×
Q4 24
Q3 24
1.16×
Q2 24
1.26×
Q1 24
1.26×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMCR
IMCR
RHLD
RHLD
Operating Cash FlowLast quarter
$-32.7M
$196.1M
Free Cash FlowOCF − Capex
$-35.5M
$189.2M
FCF MarginFCF / Revenue
-34.0%
160.8%
Capex IntensityCapex / Revenue
2.8%
5.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-15.1M
$313.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMCR
IMCR
RHLD
RHLD
Q4 25
$-32.7M
$196.1M
Q3 25
$-4.5M
$59.6M
Q2 25
$26.0M
$48.9M
Q1 25
$435.0K
$18.4M
Q4 24
$-14.0M
Q3 24
$21.1M
Q2 24
$23.5M
Q1 24
$-4.6M
Free Cash Flow
IMCR
IMCR
RHLD
RHLD
Q4 25
$-35.5M
$189.2M
Q3 25
$-5.2M
$58.6M
Q2 25
$25.6M
$47.5M
Q1 25
$137.0K
$17.8M
Q4 24
$-17.5M
Q3 24
$20.3M
Q2 24
$23.1M
Q1 24
$-5.0M
FCF Margin
IMCR
IMCR
RHLD
RHLD
Q4 25
-34.0%
160.8%
Q3 25
-5.0%
48.5%
Q2 25
26.1%
39.7%
Q1 25
0.1%
17.1%
Q4 24
-20.9%
Q3 24
25.3%
Q2 24
30.7%
Q1 24
-7.1%
Capex Intensity
IMCR
IMCR
RHLD
RHLD
Q4 25
2.8%
5.8%
Q3 25
0.7%
0.8%
Q2 25
0.4%
1.2%
Q1 25
0.3%
0.6%
Q4 24
4.3%
Q3 24
1.0%
Q2 24
0.4%
Q1 24
0.6%
Cash Conversion
IMCR
IMCR
RHLD
RHLD
Q4 25
Q3 25
Q2 25
Q1 25
0.09×
Q4 24
Q3 24
2.42×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons